lorastine tablets
bayer israel ltd - loratadine - tablets - loratadine 10 mg - other antihistamines for systemic use - seasonal allergic rhinitis, perennial allergic rhinitis, chronic urticaria.
multine
schering-plough animal health limited - clostridium novyi type b toxoid/cells; clostridium perfringens type d toxoid; clostridium tetani toxoid; clostridium septicum toxoid; clostridium chauvoei toxoid/cells - clostridium novyi type b toxoid/cells 0 vaccine; clostridium perfringens type d toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium septicum toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine - vaccine
chorulon 1500 iu
schering-plough animal health limited - gonadotrophin (gnrf poly albumin) - gonadotrophin (gnrf poly albumin) 0.3 thou iu/ml - endocrine agent (hormone)
leptavoid 2
schering-plough animal health limited - leptospira interrogans serovar pomona; leptospira interrogans serovar hardjoprajitno - leptospira interrogans serovar pomona 0 vaccine; leptospira interrogans serovar hardjoprajitno 0 vaccine - vaccine
chorulon 5000 iu
schering-plough animal health limited - gonadotrophin (gnrf poly albumin) - gonadotrophin (gnrf poly albumin) 1 thou iu/ml - endocrine agent (hormone)
estrumate
schering-plough animal health limited - cloprostenol sodium - cloprostenol sodium 0.25 g/litre - endocrine agent (hormone)
engemycin
schering-plough animal health limited - oxytetracycline - oxytetracycline 100 g/litre - antibiotic
cepravin dry cow
schering-plough animal health limited - cephalonium - cephalonium 83.3 g/kg - antibiotic
nobivac rabies
schering-plough animal health limited - rabies virus (inactivated) - rabies virus (inactivated) 0 vaccine - vaccine
avelox- moxifloxacin hydrochloride injection, solution avelox- moxifloxacin hydrochloride tablet, film coated
schering plough corporation - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg in 250 ml - avelox is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. avelox is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4 )]. avelox is indicated in adult patients for the treatment of complicated skin and ski